Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...

Innovative drug classes and advanced delivery systems are transforming the therapeutic landscape for degenerative retinal diseases, including neovascular age-related macular degeneration (nAMD ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.

The refillable eye implants continuously deliver a customised formulation of a drug over a period of several months. Read ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Instead of receiving uncomfortable eye injections around once a month for a disease that can lead to blindness, patients may ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching ...